First-in-Human Study of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET for Integrin αvβ3 Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety …

MM Clausen, EA Carlsen, C Christensen, J Madsen… - Diagnostics, 2022 - mdpi.com
Arginine-Glycine-Aspartate (RGD)-recognizing cell surface integrins are involved in tumor
growth, invasiveness/metastases, and angiogenesis, and are therefore an attractive …

Prospective phase II trial of [68Ga] Ga-NODAGA-E [c (RGDyK)] 2 PET/CT imaging of integrin αvβ3 for prognostication in patients with neuroendocrine neoplasms

EA Carlsen, M Loft, A Loft, D Czyzewska… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Integrin αvβ3, a subtype of the arginine-glycine-aspartate (RGD)–recognizing cell surface
integrins, is upregulated on endothelial cells during angiogenesis and on tumor cells …

68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging

F Buchegger, D Viertl, S Baechler… - Nuklearmedizin …, 2011 - thieme-connect.com
Aim: To visualize neovasculature and/or tumour integrin α v β 3 we selected the binding
moiety Arg-Gly-Asp-D-Tyr-Lys (RGDyK) coupled to NODAGA for labeling with 68 Ga …

Preclinical evaluation of a dual-receptor targeted tracer [68Ga]Ga-HX01 in 10 different subcutaneous and orthotopic tumor models

X Lv, X Song, Y Long, D Zeng, X Lan, Y Gai - European Journal of Nuclear …, 2023 - Springer
Purpose The integrin αvβ3 and aminopeptidase N (APN/CD13) play vital roles in the tumor
angiogenesis process. They are highly expressed in a variety of tumor cells and proliferating …

68Ga-labelled NOTA-RGD-GE11 peptide for dual integrin and EGFR-targeted tumour imaging

CJ Chen, CH Chan, KL Lin, JH Chen, CH Tseng… - Nuclear Medicine and …, 2019 - Elsevier
Introduction Multiple peptide receptors are co-expressed in many types of cancers. Arg-Gly-
Asp (RGD) and GE11 peptides specifically target integrin α V β 3 and EGFR, respectively …

[HTML][HTML] Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E [c (RGDyK)] 2 and 64Cu-NODAGA-E [c (RGDyK)] 2; in vivo imaging studies in human …

J Oxboel, M Brandt-Larsen, C Schjoeth-Eskesen… - Nuclear medicine and …, 2014 - Elsevier
Introduction The aim of this study was to synthesize and perform a side-by-side comparison
of two new tumor-angiogenesis PET tracers 68 Ga-NODAGA-E [c (RGDyK)] 2 and 64 Cu …

First-in-human study of a64Cu-labeled long-acting integrin αvβ3 targeting molecule64Cu-NOTA-EB-RGD in healthy volunteers and GBM patients

J Zhang, D Li, G Niu, R Baum, Z Zhu, X Chen - 2020 - Soc Nuclear Med
349 Objectives: This study aimed to explore the safety, biodistribution and dosimetry of a
long-acting integrin α v β 3-targeted PET tracer 64 Cu-NOTA-EB-RGD in humans, and to …

68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging

Z Liu, G Niu, J Shi, S Liu, F Wang, S Liu… - European journal of …, 2009 - Springer
Abstract Purpose Radiolabeled cyclic RGD (Arg-Gly-Asp) peptides have great potential for
the early tumor detection and noninvasive monitoring of tumor metastasis and therapeutic …

Tumor localization and mouse-derived dosimetry projection for Ga-68-NODAGA-RGD PET

F Buchegger, M Kosinski, D Viertl, C Poitry-Yamate… - 2011 - Soc Nuclear Med
1487 Objectives Tumor neovasculature compared to established vessels expresses different
integrins, in particular αvβ3 and αvβ5. The integrin-binding moiety Arg-Gly-Asp (RGD) was …

microPET imaging of glioma integrin αvβ3 expression using 64Cu-labeled tetrameric RGD peptide

Y Wu, X Zhang, Z Xiong, Z Cheng… - Journal of Nuclear …, 2005 - Soc Nuclear Med
Integrin αvβ3 plays a critical role in tumor-induced angiogenesis and metastasis and has
become a promising diagnostic indicator and therapeutic target for various solid tumors …